Dysregulation of the Golgi apparatus affects protein trafficking and secretion; recent studies show that Golgi structural proteins like GM130 and GOLM1 modulate EGFR signaling and influence NSCLC progression and prognosis [79]. Here, GOLGA2 is linked to non-small cell lung carcinoma.